retatrutide type 2 diabetes phase 2 results 2024 2025 More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the What is Retatrutide? Exploring The

When you eat 1,200-1,600 calories instead of 2,000-2,500, you get proportionally fewer vitamins and minerals

What it is being studied for not approved for Because retatrutide has no FDA approval, it should not be described as being used for type 2 diabetes, weight management, sleep apnea, or any condition in routine practice

Tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

Thymosin beta-4 is a naturally occurring peptide found in many tissues and fluids in the body

As research into the medications has continued, they have been discovered to have uses in treating other health conditions and preventing health issues, including heart disease and cancer